his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio
New data on the secondary endpoint shows up to 52.3% of adults with fibrosis stages F1, F2 and F3 had improvement in fibrosis due to MASH
This strategic decision will unlock significant value for our scientific and industrial products business
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
Merck has opened its newly expanded Life Science distribution center in Schnelldorf, Germany
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus
Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
Dual immunotherapy combination of Opdivo plus Yervoy demonstrated improved survival benefit compared to lenvatinib or sorafenib in this patient population
Subscribe To Our Newsletter & Stay Updated
